mRNA Cancer Therapies Patent Landscape 2022: Description and Analysis of Key Players, Patents & Trends
Retrieved on:
Monday, October 17, 2022
DUBLIN, Oct. 17, 2022 /PRNewswire/ -- The "mRNA Cancer Therapies Patent Landscape 2022" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- DUBLIN, Oct. 17, 2022 /PRNewswire/ -- The "mRNA Cancer Therapies Patent Landscape 2022" report has been added to ResearchAndMarkets.com's offering.
- In cancer immunotherapy, the most advanced application of mRNA is therapeutic vaccination with mRNA encoding antigens, i.e., direct cancer vaccines or dendritic cell vaccines.
- mRNA cancer therapies have been investigated and the selected patent families are labelled according to the technologies to which they relate.
- The patent portfolio analysis of key players includes a description of the assignee, key numbers in terms of patents, time evolution of patent publication, main geographical coverage and live patents by technical segment.